Cite
HARVARD Citation
Tournier, N. et al. (2021). Complete inhibition of ABCB1 and ABCG2 at the blood–brain barrier by co-infusion of erlotinib and tariquidar to improve brain delivery of the model ABCB1/ABCG2 substrate [11C]erlotinib. Journal of cerebral blood flow & metabolism. 41 (7), pp. 1634-1646. [Online].